Award
National Institute on Drug Abuse 7R01DA047924-06
Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS
Recipient
National Institute on Drug Abuse (NIDA), part of the NIH
Award Amount
$321,747.00
Ceiling
$321,747.00
Awarded
February 06, 2026
Identifier
7R01DA047924-06
NIH grant awarded to develop allosteric modulators targeting dopamine transporters for treating NeuroAIDS, with a focus on HIV-associated cognitive impairments. The project includes compound design, synthesis, characterization, and therapeutic testing in animal models.
Description
This is a renewal application for a grant from NIH (PA-24-254). The project focuses on developing allosteric modulators for monoamine transporters to treat HIV-associated cognitive impairments. The project involves designing, synthesizing, and characterizing novel compounds, and testing their therapeutic effects in animal models.